Cell Therapy CDMO — New Track in Pharmaceutical CXO Industry, the Untapped Area
The era of cell therapy has arrived, bringing hope to complex and intractable diseases, and CDMO has helped it develop rapidlyIn 2021, Fosun Kite's Akilencel injection and WuXi Junuo's Rekioll...
More+
Industry Insight | Global Lentiviral Vector CDMO Market to Grow at ~8% CAGR by 2030
Hillgene, a leading CDMO specializing in end-to-end solutions for viral vectors and cell therapies, is committed to supporting global partners with high-quality, scalable, and regulatory-compliant man...
More+
The Comprehensive Affairs Department of NMPA Solicits Public Comments on “Good Manufacturing Practice (GMP) – Appendix for Investigational Drugs (Draft for Comments)”
Chapter I ScopeArticle 1 This Appendix applies to the preparation of drugs for clinical trials (including test drugs and placebos). This Appendix also applies to changes in packaging and labeling of m...
More+
Industry Insight | Global Cell and Gene Therapy Market Projected to Reach $39.6 Billion by 2034
The global cell and gene therapy market is projected to experience rapid growth over the next decade, reaching an estimated $39.61 billion by 2034, according to a recent report from Precedence Researc...
More+
Center for Drug Evaluation (CDE) Issued the Notification of “Technical Guideline for the Clinical Risk Management Plan for Marketing Application of Chimeric Antigen Receptor T cell (CAR-T) Therapy Pro
Chimeric antigen receptor CAR-T cells (CAR-T) refer to a type of T cell that can recognize a specific antigen by introducing vectors such as viruses into autologous or allogeneic T cells through gene ...
More+
Industry Insight | Study Confirms Safety and Efficiency of Optimized K562 Feeder Cells for NK Cell Expansion
Study Confirms Safety and Efficiency of Optimized K562 Feeder Cells for NK Cell ExpansionA new study published in the Annals of Laboratory Medicine (2025) has reported significant progress in the opti...
More+
Who will become the leading “water supplier” during the “gold rush” of the cellular therapy industry?
2022 marks the 10th anniversary of Emily Whitehead, the world's first child with leukemia cured by CAR-T cell immunotherapy, achieving cancer-free survival.In 2012, Emily, who suffered from acute ...
More+
Industry Insight | Bayer Advances Parkinson’s Stem Cell Therapy into Phase III Clinical Trial
On September 22, 2025, Reuters reported that Bayer’s subsidiary BlueRock Therapeutics has officially initiated a Phase III clinical trial of its experimental stem cell therapy for Parkinson’s diseas...
More+
The Comprehensive Affairs Department of NMPA Solicits Public Comments on “Key Points for Inspection of Drug Product MAHs (Draft for Comments)”
In order to strengthen the supervision and management of drug marketing authorization holders (hereinafter referred to as holders), supervise the holders to fulfill the quality management responsibili...
More+